ENDRA Life Sciences Inc. (NDRA) Total liabilities 2016–2020
ENDRA Life Sciences Inc. (NDRA) total liabilities at each fiscal year-end, per SEC filings.
$1.6MFY2020 · since FY2016: $1.4M → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $1.6M | -33.9% |
| FY2019 | $2.4M | +147.9% |
| FY2018 | $974,583 | +14.9% |
| FY2017 | $848,214 | -38.7% |
| FY2016 | $1.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice